# A Comparative Study to Observe the Effect of Concomitant Use of Corticosteroid Treatment in Rheumatoid Arthritis (RA) Participants Who Are Treated With a Tumor Necrosis Factor (TNF) Inhibitor or Tocilizumab (TCZ) as Their Second Biological Treatment.

> **NCT02679001** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 200 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** TNF inhibitor/TCZ

## Key facts

- **NCT ID:** NCT02679001
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-24
- **Primary completion:** 2017-12-07
- **Final completion:** 2017-12-07
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2018-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02679001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02679001, "A Comparative Study to Observe the Effect of Concomitant Use of Corticosteroid Treatment in Rheumatoid Arthritis (RA) Participants Who Are Treated With a Tumor Necrosis Factor (TNF) Inhibitor or Tocilizumab (TCZ) as Their Second Biological Treatment.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02679001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*